Literature DB >> 26021381

Hypertrophic pachymeningitis with sarcoidosis: a rare cause of craniocervical compression.

Nagina Subrati1, Babar Vaqas2, David Peterson2, Maneesh C Patel3.   

Abstract

We describe a case of a 58-year-old woman with a suspected dural tumour. She presented with progressive pyramidal weakness. MRI confirmed compression of the medulla oblongata and spinal cord at the level of C1-3. The localised dural mass lesion homogenously enhanced on T1 MRI and was considered most likely to be a meningioma. Incidentally, CT scan of the chest revealed peribronchial soft tissue thickening, suggestive of pulmonary sarcoidosis. Owing to the progressive nature of her weakness, she had a posterior occipitocervical decompression with a C1-3 laminectomy and resection of the thickened dura. Histology showed densely collagenous tissue with scanty psammoma bodies and multinucleate giant cells, consistent with hypertrophic pachymeningitis (HP)-a rare, chronic inflammatory condition, characterised by thickening and fibrosis of the dura. This case demonstrates that masses in the craniocervical junction can be varied in pathology and when there is evidence of systemic inflammation, HP should be considered. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26021381      PMCID: PMC4458595          DOI: 10.1136/bcr-2014-208604

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region.

Authors:  B Voller; K Vass; J Wanschitz; K Machold; S Asenbaum; M Hoberstorfer; E Auff
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

Review 2.  "Idiopathic" cranial hypertrophic pachymeningitis responsive to antituberculous therapy: case report.

Authors:  I F Parney; E S Johnson; P B Allen
Journal:  Neurosurgery       Date:  1997-10       Impact factor: 4.654

3.  Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA), and diabetes insipidus.

Authors:  H Takuma; H Shimada; Y Inoue; E Ishimura; K Himuro; T Miki; Y Nishizawa
Journal:  Acta Neurol Scand       Date:  2001-12       Impact factor: 3.209

4.  Idiopathic hypertrophic spinal pachymeningitis.

Authors:  Moksha G Ranasinghe; Omar Zalatimo; Elias Rizk; Charles S Specht; G Timothy Reiter; Robert E Harbaugh; Jonas Sheehan
Journal:  J Neurosurg Spine       Date:  2011-05-13

5.  Idiopathic hypertrophic spinal pachymeningitis : report of two cases and review of the literature.

Authors:  Jee Hee Kim; Young Mok Park; Dong Kyu Chin
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

Review 6.  Recurrence of hypertrophic spinal pachymeningitis. Report of two cases and review of the literature.

Authors:  Zenya Ito; Yoshimitsu Osawa; Yukihiro Matsuyama; Takaaki Aoki; Atsushi Harada; Naoki Ishiguro
Journal:  J Neurosurg Spine       Date:  2006-06

7.  Idiopathic hypertrophic cervical pachymeningitis: a case report with 5 year follow up.

Authors:  S V Khadilkar; K Menezes; H N Parekh; M Ursekar; S N Bhagwati
Journal:  J Assoc Physicians India       Date:  2003-04

Review 8.  Idiopathic hypertrophic pachymeningitis.

Authors:  M J Kupersmith; V Martin; G Heller; A Shah; H J Mitnick
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

Review 9.  Idiopathic chronic hypertrophic craniocervical pachymeningitis: case report.

Authors:  C Botella; M Orozco; J Navarro; P Riesgo
Journal:  Neurosurgery       Date:  1994-12       Impact factor: 4.654

Review 10.  Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.

Authors:  T Bosman; C Simonin; D Launay; S Caron; A Destée; L Defebvre
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

View more
  1 in total

Review 1.  A case report of atypical long segmental thoracic hypertrophic pachymeningitis with ossification of ligamentum flavum and literature review.

Authors:  Ruofu Tang; Fangcai Li; Qixin Chen
Journal:  Eur Spine J       Date:  2017-04-01       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.